K.J. Harrison & Partners Inc purchased a new position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 24,300 shares of the company's stock, valued at approximately $1,529,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Lake Street Advisors Group LLC grew its holdings in Corteva by 3.7% during the fourth quarter. Lake Street Advisors Group LLC now owns 4,514 shares of the company's stock worth $257,000 after purchasing an additional 160 shares during the period. Sepio Capital LP lifted its position in shares of Corteva by 3.2% in the fourth quarter. Sepio Capital LP now owns 5,361 shares of the company's stock valued at $305,000 after buying an additional 166 shares during the last quarter. Allred Capital Management LLC boosted its stake in shares of Corteva by 3.2% during the 4th quarter. Allred Capital Management LLC now owns 5,447 shares of the company's stock worth $310,000 after acquiring an additional 171 shares during the period. PFG Investments LLC increased its holdings in shares of Corteva by 1.4% during the 1st quarter. PFG Investments LLC now owns 12,867 shares of the company's stock worth $810,000 after acquiring an additional 180 shares during the last quarter. Finally, Legacy Advisors LLC raised its stake in Corteva by 2.2% in the 1st quarter. Legacy Advisors LLC now owns 8,697 shares of the company's stock valued at $547,000 after acquiring an additional 188 shares during the period. Institutional investors and hedge funds own 81.54% of the company's stock.
Corteva Stock Up 0.1%
Shares of Corteva stock traded up $0.10 on Monday, hitting $74.49. The company had a trading volume of 3,201,554 shares, compared to its average volume of 3,389,382. The stock has a market capitalization of $50.81 billion, a price-to-earnings ratio of 45.42, a P/E/G ratio of 1.90 and a beta of 0.75. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.00 and a current ratio of 1.44. Corteva, Inc. has a 1 year low of $50.30 and a 1 year high of $75.05. The stock has a 50 day moving average of $68.57 and a 200-day moving average of $63.42.
Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $1.13 earnings per share for the quarter, topping analysts' consensus estimates of $0.88 by $0.25. Corteva had a net margin of 6.77% and a return on equity of 7.84%. The company had revenue of $4.42 billion for the quarter, compared to the consensus estimate of $4.56 billion. During the same period in the previous year, the firm earned $0.89 EPS. The firm's quarterly revenue was down 1.7% on a year-over-year basis. As a group, sell-side analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.
Corteva Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Friday, May 2nd were given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.91%. The ex-dividend date was Monday, June 2nd. Corteva's dividend payout ratio is presently 41.46%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on the company. Barclays boosted their price objective on Corteva from $64.00 to $70.00 and gave the stock an "equal weight" rating in a report on Wednesday, May 14th. Citigroup boosted their price target on Corteva from $75.00 to $78.00 and gave the company a "buy" rating in a research note on Friday, May 9th. Morgan Stanley increased their price objective on Corteva from $65.00 to $71.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. UBS Group boosted their target price on shares of Corteva from $74.00 to $76.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Finally, KeyCorp raised their price target on shares of Corteva from $71.00 to $72.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Three equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. Based on data from MarketBeat, Corteva has a consensus rating of "Moderate Buy" and a consensus target price of $72.08.
Read Our Latest Report on CTVA
Corteva Profile
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Further Reading
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
